Cita APA

Verger, A., Yakushev, I., Albert, N., van Berckel, B., Brendel, M., Cecchin, D., . . . Barthel, H. (2023). FDA approval of lecanemab: The real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective.

Citación estilo Chicago

Verger, A., et al. FDA Approval of Lecanemab: The Real Start of Widespread Amyloid PET Use? - the EANM Neuroimaging Committee Perspective. 2023.

Cita MLA

Verger, A., et al. FDA Approval of Lecanemab: The Real Start of Widespread Amyloid PET Use? - the EANM Neuroimaging Committee Perspective. 2023.